May 18, 2026 07:06AM
May 18, 2026 07:05AM
May 18, 2026 07:00AM
Mar 23, 2026 03:12AM
Mar 17, 2026 04:01PM
Feb 24, 2026 04:34AM
Feb 24, 2026 12:43AM Leerink Partners Downgrades Gossamer Bio Inc. (GOSS) to Market Perform
Feb 23, 2026 08:00AM
Feb 23, 2026 08:00AM
Nov 13, 2025 07:29AM
Sep 25, 2025 07:41AM
Sep 25, 2025 07:41AM
Sep 25, 2025 07:31AM
Sep 25, 2025 07:31AM Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
May 15, 2025 04:01PM
Oct 31, 2024 07:00AM
Mar 12, 2024 07:32AM
Mar 12, 2024 07:31AM
May 18, 2023 07:05AM
May 9, 2023 04:01PM
Apr 3, 2023 04:04PM Gossamer Bio Inc. (GOSS) announces FDA has placed a partial clinical hold on all trials of GB5121 in response to serious adverse events
Mar 17, 2023 07:31AM
Apr 25, 2022 08:54AM
Mar 3, 2022 04:01PM
Mar 5, 2021 06:23PM
Feb 25, 2021 07:31AM
Dec 7, 2020 07:03AM
Oct 13, 2020 07:05AM Gossamer Bio(GOSS) Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis Did Not Achieve Statistical Significance on Primary Endpoint
Oct 13, 2020 07:04AM
Sep 1, 2020 04:30PM
May 27, 2020 04:36PM
May 27, 2020 04:30PM
May 27, 2020 04:30PM
May 12, 2020 04:01PM
Nov 12, 2019 04:05PM Gossamer Bio Announces Third Quarter 2019 Financial Results
Nov 12, 2019 07:13AM
Nov 12, 2019 07:00AM
May 14, 2019 06:00AM

322,900 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All